Pars Darou Company (DPARS) income statement
Operating revenue through to net profit and earnings per share
- Ticker
- DPARS
- Industry
- Pharmaceuticals
- Market
- Tehran Stock Exchange
Latest periods
| Item | To 1405/06/31 | To 1404/06/31 | To 1403/06/31 | To 1402/06/31 | To 1401/06/31 | To 1400/06/31 |
|---|---|---|---|---|---|---|
| Operating revenue | 34,846,993 | 9,688,918 | 7,479,157 | 6,929,337 | 4,053,422 | 2,606,773 |
| Cost of operating revenue | -16,378,087 | -6,006,585 | -4,483,198 | -3,077,023 | -2,230,306 | -1,428,443 |
| Gross profit (loss) | 18,468,906 | 3,682,333 | 2,995,959 | 3,852,314 | 1,823,116 | 1,178,330 |
| Selling, general and administrative expenses | -1,089,761 | -572,268 | -353,600 | -243,336 | -209,144 | -302,340 |
| Other income | 32,764 | 15,308 | 2,431 | 4,945 | 12,245 | 5,082 |
| Other expenses | -219,042 | -3,846 | 0 | -715 | -10,516 | -270 |
| Operating profit (loss) | 17,192,867 | 3,121,527 | 2,644,790 | 3,613,208 | 1,615,701 | 880,802 |
| Finance costs | -1,060,880 | -311,115 | -321,442 | -383,259 | -324,970 | -261,026 |
| Other non-operating income and expenses | 75,170 | 33,795 | 847,031 | 627 | 4,523 | 5,462 |
| Profit (loss) from continuing operations before tax | 16,207,157 | 2,844,207 | 3,170,379 | 3,230,576 | 1,295,254 | 625,238 |
| Current year tax | -3,646,610 | -632,508 | -525,938 | -726,810 | -291,282 | -139,556 |
| Net profit (loss) from continuing operations | 12,560,547 | 2,211,699 | 2,644,441 | 2,503,766 | 1,003,972 | 485,682 |
| Net profit (loss) | 12,560,547 | 2,211,699 | 2,644,441 | 2,503,766 | 1,003,972 | 485,682 |
| Basic earnings (loss) per share | 5,932 rials | 917 rials | 2,784 rials | 2,636 rials | 1,056 rials | 926 rials |
| Net earnings (loss) per share, rials | 5,127 rials | 903 rials | 2,784 rials | 2,636 rials | 1,057 rials | 926 rials |
| Capital | 2,450,000 | 2,450,000 | 950,000 | 950,000 | 950,000 | 525,000 |
Reporting periods
91 periods are on file for this report, from the period ending 1380/12/29 to the period ending 1405/06/31.